GlassScriptPhysician profile
Lucien Alexandre
NPI 1104111012
$18,419.55
in general payments reported to CMS, 2019-2025
36 companies · $1,294 in 2025
The $1,294 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,447 · 2020: $219 · 2021: $3,228 · 2022: $4,640 · 2023: $5,209 · 2024: $2,381 · 2025: $1,294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,333 · Travel and Lodging: $2,522 · Gift: $30.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,333.14 |
| Travel and Lodging | $2,521.65 |
| Gift | $30.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,134.57 | 2019-2025 | Proclaim, Eterna |
| Nalu Medical, INC. | $2,578.41 | 2021-2024 | Nalu Neurostimulation System |
| Spinal Simplicity, LLC | $2,201.42 | 2021-2025 | Ha Minuteman G3-R |
| Genesys Orthopedics Systems, L.L.C. | $2,172.24 | 2023 | Sacroiliac Joint Fusion System, Sacroiliac Joint Fusion System |
| Nevro Corp. | $1,697.65 | 2019-2024 | Senza |
| Relievant Medsystems, INC. | $752.02 | 2021-2023 | Intracept |
| Aurora Spine, INC. | $691.21 | 2022 | |
| Globus Medical, INC. | $492.71 | 2025 | Senza, Vyrsa V1 |
| Vertos Medical, INC. | $450.35 | 2019-2024 | Mild Device Kit |
| Spr Therapeutics, INC | $440.72 | 2022-2025 | Sprint Pns System |
| Abbvie INC. | $409.57 | 2022-2025 | Botox |
| Boston Scientific Corporation | $395.13 | 2021-2024 | |
| Medtronic, INC. | $319.34 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Kyphon Express II Kyphopak Tray |
| Stryker Corporation | $285.15 | 2023-2025 | Vitoss, Mild Device Kit |
| Si-Bone, INC. | $257.35 | 2019-2025 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $218.82 | 2023-2025 | Vyepti |
| Painteq LLC | $162.90 | 2024 | Painteq |
| Stimwave Technologies Incorporated | $118.80 | 2019-2020 | |
| Bioventus LLC | $88.96 | 2022-2023 | Stimrouter Implantable Kit |
| Nuvasive, INC. | $84.26 | 2021 | |
| Medtronic USA, INC. | $81.77 | 2019 | |
| Averitas Pharma INC. | $69.65 | 2024-2025 | Qutenza |
| Allergan, INC. | $40.01 | 2022 | |
| Biotronik Nro, INC. | $27.78 | 2024 | Prospera |
| Vertex Pharmaceuticals Incorporated | $26.35 | 2025 | |
| Mml US, INC. | $24.87 | 2023 | Reactiv8 |
| Camber Spine Technologies LLC | $23.89 | 2023 | |
| Saluda Medical Americas, INC. | $23.52 | 2025 | Evoke |
| Pfizer INC. | $22.78 | 2025 | |
| Horizon Therapeutics Plc | $22.54 | 2022 | |
| Ibsa Pharma INC. | $20.73 | 2024 | Tirosint, Licart |
| Novo Nordisk INC | $19.63 | 2025 | Wegovy |
| Avion Pharmaceuticals | $18.28 | 2022 | |
| Sanofi-Aventis U.S. LLC | $16.07 | 2019 | |
| Endo Pharmaceuticals INC. | $15.36 | 2019 | |
| Curonix LLC | $14.74 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucien Alexandre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.